Michal is Regional Head of Johnson & Johnson Innovation LLC, East North America. Located at the Innovation Center in Cambridge, she leads the Johnson & Johnson Innovation team to curate and cultivate the most promising, early-stage healthcare innovations in the region, spanning across pharmaceutical, consumer health and medical devices.
Prior to joining Johnson & Johnson Innovation, Michal served as the Executive Director of Harvard University’s Office of Technology Development (OTD) Harvard Medical School site, where she was responsible for development and commercialization of technologies emerging from research at HMS laboratories and for the strategy and execution of all industry collaborations. She negotiated agreements with major biopharma, life sciences, food and cosmetics companies to advance the translation of discoveries into products and create a revenue-generating product pipeline and worked with scientific founders and investors to create new startup companies.
Before joining Harvard University’s OTD in 2005, Michal held several senior business and technology development leadership positions in the biotech and tech industries and co-founded a biotechnology startup.
Michal serves on the Board of Directors for MassBio and the Kendall Square Association (KSA). She is also a member of the Scientific Advisory Board and serves on the Scientific Advisory Board's FutuRx Accelerator, as well as on the Advisory Board for the Binah Initiative at the Weizmann Institute of Science.
Prior to joining Johnson & Johnson Innovation, Michal served as the Executive Director of Harvard University’s Office of Technology Development (OTD) Harvard Medical School site, where she was responsible for development and commercialization of technologies emerging from research at HMS laboratories and for the strategy and execution of all industry collaborations. She negotiated agreements with major biopharma, life sciences, food and cosmetics companies to advance the translation of discoveries into products and create a revenue-generating product pipeline and worked with scientific founders and investors to create new startup companies.
Before joining Harvard University’s OTD in 2005, Michal held several senior business and technology development leadership positions in the biotech and tech industries and co-founded a biotechnology startup.
Michal serves on the Board of Directors for MassBio and the Kendall Square Association (KSA). She is also a member of the Scientific Advisory Board and serves on the Scientific Advisory Board's FutuRx Accelerator, as well as on the Advisory Board for the Binah Initiative at the Weizmann Institute of Science.
Speaking In
2:45 PM - 3:00 PM
Tuesday, June 6
